The present invention relates to a genetically modified hematopoietic stem cell
(HSC) comprising, in at least one α-globin gene comprised in the genome thereof, at least
one transgene encoding a functional β-like globin protein, the said transgene being placed
under the control of the endogenous promoter of the said at least one α-globin gene